Active, not recruitingPhase 1NCT03818763

Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medical College of Wisconsin
Principal Investigator
Mary Eapen, MD
Froedtert Hosptial and Medical College of Wisconsin
Intervention
Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII(biological)
Enrollment
5 enrolled
Eligibility
18 years · MALE
Timeline
2020 – 2033

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03818763 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials